Effects of Omega-3 Fatty Acids on Outcome After Major Liver Resection
NCT01884948
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
258
Enrollment
OTHER
Sponsor class
Conditions
Major Liver Surgery
Interventions
DRUG:
Omegaven™
Sponsor
University of Zurich